Abstract
Farnesol is a quorum-sensing molecule that inhibits biofilm formation in Candida albicans. Previous in vitro data suggest that, in combination with certain antifungals, farnesol may have an adjuvant anti-biofilm agent. However, the in vivo efficacy of farnesol is very questionable. Therefore, the in vitro and in vivo activity of fluconazole combined with farnesol was evaluated against C. albicans biofilms using fractional inhibitory concentration index (FICI) determination, time-kill experiments and a murine vulvovaginitis model. The median biofilm MICs of fluconazole-sensitive C. albicans isolates ranged between 4 -> 512 mg/L and 150–300 μM for fluconazole and farnesol, respectively. These values were 512 -> 512 mg/L and > 300 μM for fluconazole-resistant clinical isolates. Farnesol decreased the median MICs of fluconazole by 2-64-fold for biofilms. Based on FICI, synergistic interaction was observed only in the case of the sessile SC5314 reference strain (FICIs: 0.16–0.27). In time-kill studies, only the 512 mg/L fluconazole and 512 mg/L fluconazole + 75 μM farnesol reduced biofilm mass significantly at each time point in the case of all isolates. The combination reduced the metabolic activity of biofilms for all isolates in a concentration- and time-dependent manner. Our findings revealed that farnesol alone was not protective in a murine vulvovaginitis model. Farnesol was not beneficial in combination with fluconazole for fluconazole-susceptible isolates, but partially increased fluconazole activity against one fluconazole-resistant isolate, but not the other one.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 3rd ed. M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
Cordeiro, R.A., Teixeira, C.E., Brilhante, R.S., Castelo-Branco, D.S., Paiva, M.A., Giffoni Leite, J.J., Lima, D.T., Monteiro, A.J., Sidrim, J.J., and Rocha, M.F. 2013. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol. Med. Mycol. 51, 53–59.
De Cremer, K., Staes, I., Delattin, N., Cammue, B.P., Thevissen, K., and De Brucker, K. 2015. Combinatorial drug approaches to tackle Candida albicans biofilms. Expert Rev. Anti Infect. Ther. 13, 973–984.
Elizondo-Zertuche, M., Robledo-Leal, E., González, J.G., Ceceñas, L.A., and González, G.M. 2015. Efficacy of ravuconazole in a murine model of vaginitis by Candida albicans. Rev. Iberoam. Micol. 32, 30–33.
Fidel, P.L.Jr., Cutright, J., and Steele, C. 2000. Effects of reproductive hormones on experimental vaginal candidiasis. Infect. Immun. 68, 651–657.
Ganguly, S. and Mitchell, A.P. 2011. Mucosal biofilms of Candida albicans. Curr. Opin. Microbiol. 14, 380–385.
González, G.M., Robledo, E., Saldívar, D., González, G., Bosques, F., and Garza, E. 2007. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model. Med. Mycol. 45, 221–224.
Han, T.L., Cannon, R.D., and Villas-Bôas, S.G. 2012. The metabolic response of Candida albicans to farnesol under hyphae-inducing conditions. FEMS Yeast Res. 12, 879–889.
Harriott, M.M., Lilly, E.A., Rodriguez, T.E., Fidel, P.L.Jr., and Noverr, M.C. 2010. Candida albicans forms biofilms on the vaginal mucosa. Microbiology 156, 3635–3644.
Hawser, S. 1996. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells. J. Med. Vet. Mycol. 34, 149–152.
Hisajima, T., Maruyama, N., Tanabe, Y., Ishibashi, H., Yamada, T., Makimura, K., Nishiyama, Y., Funakoshi, K., Oshima, H., and Abe, S. 2008. Protective effects of farnesol against oral candidiasis in mice. Microbiol. Immunol. 52, 327–333.
Hornby, J.M., Jensen, E.C., Lisec, A.D., Tasto, J.J., Jahnke, B., Shoemaker, R., Dussault, P., and Nickerson, K.W. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67, 2982–2992.
Hornby, J.M. and Nickerson, K.W. 2004. Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob. Agents Chemother. 48, 2305–2307.
Jabra-Rizk, M.A., Shirtliff, M., James, C., and Meiller, T. 2006. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance. FEMS Yeast Res. 6, 1063–1073.
Katragkou, A., McCarthy, M., Alexander, E.L., Antachopoulos, C., Meletiadis, J., Jabra-Rizk, M.A., Petraitis, V., Roilides, E., and Walsh, T.J. 2015. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. J. Antimicrob. Chemother. 70, 470–478.
Kovács, R., Bozó, A., Gesztelyi, R., Domán, M., Kardos, G., Nagy, F., Tóth, Z., Majoros, L. 2016. Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms. Int. J. Antimicrob. Agents 47, 304–310.
Kovács, R., Czudar, A., Horváth, L., Szakács, L., Majoros, L., and Kónya, J. 2014. Serum interleukin-6 levels in murine models of Candida albicans infection. Acta Microbiol. Immunol. Hung. 61, 61–69.
Langford, M.L., Atkin, A.L., and Nickerson, K.W. 2009. Cellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicans. Future Microbiol. 4, 1353–1362.
Louie, A., Banerjee, P., Drusano, G.L., Shayegani, M., and Miller, M.H. 1999. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or-resistant strains of Candida albicans. Antimicrob. Agents Chemother. 43, 2841–2847.
Martins, M., Lazzell, A.L., Lopez-Ribot, J.L., Henriques, M., and Oliveira, R. 2012. Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis. J. Basic Microbiol. 52, 487–491.
Meletiadis, J., Verweij, P.E., TeDorsthorst, D.T., Meis, J.F., and Mouton, J.W. 2005. Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models. Med. Mycol. 43, 133–152.
Navarathna, D.H., Hornby, J.M., Krishnan, N., Parkhurst, A., Duhamel, G.E., and Nickerson, K.W. 2007. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect. Immun. 75, 1609–1618.
O’Toole, G.A. 2011. Microtiter dish biofilm formation assay. J. Vis. Exp. 47, pii: 2437.
Pfaller, M.A., Andes, D., Diekema, D.J., Espinel-Ingroff, A., Sheehan, D., and CLSI Subcommittee for Antifungal Susceptibility Testing. 2010. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist. Updat. 13, 180–195.
Pierce, C.G., Srinivasan, A., Uppuluri, P., Ramasubramanian, A.K., and López-Ribot, J.L. 2013. Antifungal therapy with an emphasis on biofilms. Curr. Opin. Pharmacol. 13, 726–730.
Pierce, C.G., Uppuluri, P., Tristan, A.R., Wormley, F.L.Jr., Mowat, E., Ramage, G., and Lopez-Ribot, J.L. 2008. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 3, 1494–1500.
Ramage, G., Saville, S.P., Wickes, B.L., and López-Ribot, J.L. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68, 5459–5463.
Sharma, M. and Prasad, R. 2011. The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans. Antimicrob. Agents Chemother. 55, 4834–4843.
Uppuluri, P., Chaturvedi, A.K., Srinivasan, A., Banerjee, M., Ramasubramaniam, A.K., Köhler, J.R., Kadosh, D., and Lopez-Ribot, J.L. 2010. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog. 6, e1000828.
Zhou, Y., Wang, G., Li, Y., Liu, Y., Song, Y., Zheng, W., Zhang, N., Hu, X., Yan, S., and Jia J. 2012. In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis. Antimicrob. Agents Chemother. 56, 3250–3260.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bozó, A., Domán, M., Majoros, L. et al. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model. J Microbiol. 54, 753–760 (2016). https://doi.org/10.1007/s12275-016-6298-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-016-6298-y